HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-(5-[(3-chloropropyl)thio]-4-methyl-4H-1,2,4-triazol-3-yl)-2-methylquinoline → HCID 67358767, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-(5-[(3-chloropropyl)thio]-4-methyl-4H-1,2,4-triazol-3-yl)-2-methylquinoline | HCID 25105050 | — |
| Reactant | HCID 59150528 | HCID 59150528 | — |
| Product | HCID 67358767 | HCID 67358767 | — |
Reaction Steps
The title compound was prepared in analogy to General Procedure 1 from 2-methyl-6,7,8,9-tetrahydro-5H-[1,3]thiazolo[4,5-h][3]benzazepine (0.13 mmol) and 5-{5-[(3-chloropropyl)thio]-4-methyl-4H-1,2,4-triazol-3-yl}-2-methylquinoline (0.16 mmol) and was obtained as a colourless slightly hygroscopic solid (24 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07989444B2 |
| Source dataset | uspto-grants-2011_08 |
| ORD ID | ord-6c5acbeb5c6046198122aa8c0310d58d |
| Source note | uspto-grants-2011_08 |